Cellular Analysis News Today

Bruker Corporation (NASDAQ:BRKR) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Greetings, ladies and gentlemen. Thank you for attending today’s conference call. I would now like to turn the call over to Justin Ward, Head of Investor Relations. Please go ahead. Justin Ward: Thank you and good morning. I would like to welcome everyone […]

Justin Ward: Thank you and good morning. I would like to welcome everyone to Bruker Corporation’s third quarter 2023 earnings conference call.

Q3 2023 revenues of $742.8 million, up 16.3% year-over-year ; organic revenue up 10.9% yoy Q3 2023 GAAP EPS $0.60; non-GAAP EPS $0.74, up 12.1% yoy Bruker increases FY 2023 revenue guidance to...

Originally published June 27 on KTVB.COM.MOSCOW — Latah County prosecutors have filed their intent to seek the death penalty against Bryan Kohberger, and his defense is doing everything it can

In court Tuesday, Kohberger's attorney said she is asking for more evidence she claims the state has not yet turned over.

LevitasBio, Inc. (www.levitasbio.com), a premier end-to-end sample processing and cellular analysis provider to the life sciences market, unveils a suite of LeviSelect™ cell depletion and enrichment kits for immunology research.

/PRNewswire/ -- The "Cell Analysis Global Market - Forecast to 2029" report has been added to ResearchAndMarkets.coms offering. According to analysis, the...

/PRNewswire/ -- The "Cell Analysis Global Market - Forecast to 2027" report has been added to ResearchAndMarkets.coms offering. The cell analysis global...